Sangamo Therapeutics, Inc.【SGMO】 業績推移・財務諸表

機能の使い方
(単位:%) 2Q11 3Q11 4Q11 1Q12 2Q12 3Q12 4Q12 1Q13 2Q13 3Q13 4Q13 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 3Q16 4Q16 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23 4Q23 1Q24 2Q24 3Q24 4Q24 1Q25 3Q25 4Q25
売上高 1,514 1,857 4,748 3,242 4,574 4,907 8,931 4,623 6,934 5,707 6,869 8,116 10,385 12,417 14,952 13,491 8,358 8,569 9,121 3,942 3,702 2,823 8,922 3,425 8,253 11,812 13,077 12,637 21,416 23,562 26,837 8,071 17,548 21,958 54,851 13,076 21,553 57,763 25,800 26,280 27,872 28,563 27,986 28,231 29,378 26,460 27,230 157,957 6,835 9,398 2,042 481 356 49,412 7,551 6,437 581 14,228
売上成長率(%) - - - - 425.8 269.8 1238.3 -98.8 88.4
研究開発費 8,119 7,839 7,878 7,283 7,574 7,570 9,282 8,220 9,278 8,703 10,778 12,033 13,430 16,290 14,991 14,980 15,618 16,694 19,906 15,266 19,454 17,008 13,890 12,942 14,984 18,425 19,377 23,547 29,255 28,810 33,254 34,850 36,455 36,288 38,329 41,479 41,523 45,287 52,358 56,434 60,086 62,498 51,801 58,584 60,019 65,116 66,179 63,216 63,046 57,089 50,706 35,891 24,223 27,732 23,675 26,006 28,142 31,438
営業費用 11,795 11,431 11,113 10,525 10,318 10,709 12,300 11,528 12,402 11,866 15,043 15,727 17,432 20,071 19,421 19,712 20,635 21,254 24,794 20,623 30,544 22,029 18,752 20,217 21,021 24,847 26,843 33,634 40,556 39,803 47,609 51,968 51,052 51,206 53,382 57,598 59,450 61,464 69,232 72,582 76,572 76,999 67,885 73,492 75,112 81,354 82,622 139,923 130,407 115,806 64,101 52,007 37,440 38,781 33,541 36,065 36,134 52,431
営業利益 -10,281 -9,574 -6,365 -7,283 -5,744 -5,802 -3,369 -6,905 -5,468 -6,159 -8,174 -7,611 -7,047 -7,654 -4,469 -6,221 -12,277 -12,685 -15,673 -16,681 -26,842 -19,206 -9,830 -16,792 -12,768 -13,035 -13,766 -20,997 -19,140 -16,241 -20,772 -43,897 -33,504 -29,248 1,469 -44,522 -37,897 -3,701 -43,432 -46,302 -48,700 -48,436 -39,899 -45,261 -45,734 -54,894 -55,392 18,034 -123,572 -106,408 -62,059 -51,526 -37,084 10,631 -25,990 -29,628 -35,553 -38,203
営業利益率 (%) 21.5 -344.2 -460.3 -6119.3 -268.5
経常(税引前)利益 - - - - - - - - - - - - - - - -6,067 -12,126 -12,584 -15,648 -16,494 -26,599 -18,968 -9,611 - -12,491 -12,354 -13,091 - - - - - - - - - - -1,271 - -45,677 -47,150 -47,602 - -43,919 -43,091 -53,125 - 21,327 -120,770 -102,893 -60,567 -48,991 -36,054 10,760 -23,823 -30,478 -35,091 -37,972
経常(税引前)利益率(%) - - - - - - - - - - - - - - - -45.0 -145.1 -146.9 -171.6 -418.4 -718.5 -671.9 -107.7 - -151.4 -104.6 -100.1 - - - - - - - - - - -2.2 - -173.8 -169.2 -166.7 - -155.6 -146.7 -200.8 - 13.5 -1766.9 -1094.8 -2966.1 -10185.2 -10127.5 21.8 -315.5 -473.5 -6039.8 -266.9
法人税等合計 - - - - - - - - - - - - - - - -748 0 -3,339 -1,635 - -24 -3 13 - - - - - - - - - - - - - - 237 145 300 24 100 -94 58 82 30 229 200 -6,300 1,300 -272 98 74 88 -427 119 -161 -553
実効税率(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0.8 1.8 -0.4 0.5 1.5
純利益 -10,259 -9,554 -6,359 -7,268 -5,728 -5,790 -3,478 -6,885 -5,450 -6,145 -8,144 -7,572 -6,981 -7,545 -4,319 -5,319 -12,126 -9,245 -14,013 -16,494 -26,575 -18,965 -9,624 -16,632 -12,491 -12,354 -13,091 -20,187 -16,640 -12,843 -18,664 -42,150 -30,284 -27,307 4,555 -42,913 -35,929 -1,508 -40,604 -45,933 -47,169 -47,688 -37,496 -43,977 -43,173 -53,155 -51,973 21,133 -114,506 -104,163 -60,295 -49,089 -36,128 10,672 -23,396 -30,597 -34,930 -37,419
純利益率(%) 21.6 -309.8 -475.3 -6012.0 -263.0
一株あたり利益 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -0.33 -0.33 -0.25 -0.3 -0.29 -0.34 -0.32 0.13 -0.66 -0.59 -0.34 -0.27 -0.18 0.05 -0.12 -0.14 -0.11 -0.11
希薄化後一株あたり利益 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -0.33 -0.33 -0.25 -0.3 -0.29 -0.34 -0.32 0.12 -0.66 -0.59 -0.34 -0.27 -0.18 0.04 -0.12 -0.14 -0.11 -0.11
EBITDA - 11,849 -24,756 -28,608 - -37,205
EBITDAマージン(%) - 24.0 -327.9 -444.4 - -261.5